Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 318

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 318
---
ary would reasonably be expected to be liable after the Effective Date for any Tax liability of any person that is neither the Company nor the Subsidiary, other than any customary provisions contained in any 
 commercial agreement entered into in the ordinary course of business and not primarily relating to Tax (such agreements, “Ordinary Course Contracts”). Neither the Company nor the Subsidiary has any material liability for Taxes of           
 any person (other than the Company or the Subsidiary) under Treasury Regulations Section 1.1502-6 (or any similar provision of U.S. state or local Law), or as a transferee or successor, by assumption or                                      
 operation of Law or by contract (except, in each case, for liabilities incurred in connection with Ordinary Course Contracts).                                                                                                                  |

| (h) | Neither the Company the Subsidiary has participated, or is currently participating, in a “listed                                                       
 transaction,” as defined in Treasury Regulations Sections 1.6011-4(b)(2) or any comparable, analogous or similar provision of U.S. state or local Law. |

| (i) | Neither the Company nor the Subsidiary has constituted a “distributing corporation” or a                                                                                                                
 “controlled corporation” in a distribution of stock intended to qualify for tax-free treatment under Section 355 of the Code (or so much of Section 356 of the Code as relates to                       
 Section 355 of the Code) (i) in the two years prior to the date of this Agreement or (ii) as part of a “plan” or “series of related transactions” (within the meaning of Section 355(e) of the Code) in 
 conjunction with the transactions contemplated by the Agreement.                                                                                                                                        |

| (j) | There are no Encumbrances for material Taxes on any of the assets of the Company or the Subsidiary, except for 
 Encumbrances described in clause (v) of the definition of Permitted Encumbrances.                              |

| (k) | For U.S. federal income tax purposes, neither the Company nor the Subsidiary will be required to include any                                                                                                                                             
 material item of income in, or to exclude any material item of deduction from, taxable income in any taxable period (or portion thereof) ending after the Effective Date as a result of any closing agreement, installment sale or open transaction      
 entered into on or prior to the Effective Date, any accounting method change or agreement with any governmental authority with respect